Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of shares under Syngene Restricted Stock Units Long Term Incentive Plan FY 2020.24-04-2024
24-04-2024
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Dividend Updates
The Board of Directors recommends Final Dividend of Rs. 1.25/- per share.24-04-2024
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release dated April 24, 2024.24-04-2024
Syngene International Ltd - 539268 - Audited Financial Results For The Quarter And Year Ended March 31, 2024.
Audited Financial Results for the quarter and year ended March 31, 2024.24-04-2024
Syngene International Ltd - 539268 - Board Meeting Outcome for Outcome Of The Board Meeting - April 24, 2024
Outcome of the Board Meeting - April 24, 202424-04-2024
Syngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation regarding submission of appeal before the Commissioner of Income-tax (Appeals).22-04-2024
Syngene International Ltd - 539268 - Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance Certificate under Regulation 40 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.16-04-2024
Syngene International Ltd - 539268 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.12-04-2024
Syngene International Ltd - 539268 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.12-04-2024
Syngene To Neuland And Laurus: Goldman Sachs Initiates Coverage As India Expands Global Pharma Supply
Goldman Sachs remains optimistic about India's strong position within the global pharmaceutical outsourcing landscape.12-04-2024